Details for New Drug Application (NDA): 202736
✉ Email this page to a colleague
The generic ingredient in SKLICE is ivermectin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
Summary for 202736
Tradename: | SKLICE |
Applicant: | Arbor Pharms Llc |
Ingredient: | ivermectin |
Patents: | 0 |
Suppliers and Packaging for NDA: 202736
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SKLICE | ivermectin | LOTION;TOPICAL | 202736 | NDA | Azurity Pharmaceuticals | 24338-185 | 24338-185-04 | 1 TUBE in 1 CARTON (24338-185-04) / 117 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | LOTION;TOPICAL | Strength | 0.5% | ||||
Approval Date: | Feb 7, 2012 | TE: | RLD: | Yes |
Expired US Patents for NDA 202736
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription